Biopharmaceutical Veteran Joins CURE Pharmaceutical to Lead Manufacturing

GlobeNewswire•March 14, 2018 LOS ANGELES, March 14, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical, (CURR), an innovative drug delivery and development company, today named Steven Ruhl Vice President of Manufacturing. Bringing more than 35 years of experience, Ruhl will oversee all process development and manufacturing operations. “Steven has a proven track record of building and developing…